ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2025
Parkinson's disease and reading performance.
Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Eye-Tracking Assessment of Visual, Oculomotor, and Pupillary Biomarkers During Reading in Parkinson's Disease.Life (Basel, Switzerland) · 2026Article
- A Sensorimotor Framework for the Neurorehabilitation of Oculomotor Dysfunction in Parkinson's Disease.Journal of clinical medicine · 2026Review
- Comparison of binocular vision indices in Parkinson's disease patientsInternational journal of ophthalmology · 2026Article
- Parkinson's disease and reading performance.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeVisual and reading difficulties affect 80% of individuals with Parkinson's disease (PD). Despite this, reading speed (RS) in PD has not been studied extensively. This investigation aimed to compare RS and reading acuity (RA) in participants with PD and in a control group (CG) using the Radner-Vissum reading charts.
methodsCG inclusion criteria included no visual/systemic or neurodegenerative diseases, no medications affecting vision, the ability to follow test instructions and providing informed consent. For PD participants, they were diagnosed by a neurologist, classified by the Hoehn and Yahr scale, received no vision therapy and had no dementia. Fifty-two participants were recruited in each group. The Radner-Vissum reading charts assessed RA and RS. Participants read sentences aloud with their optimal refractive correction. Analysed variables included: age, sex, RA, corrected RA score, maximum, mean and minimum RS (MAX-RS, MEAN-RS and MIN-RS), total words per minute (wpm) read, distance to near visual acuity ratio and critical print size (CPS).
resultsPD participants exhibited reduced RS and RA, made more reading errors and had poorer RA scores than the CG (-0.05 vs. 0.08, p < 0.001). MAX-RS (201 vs. 191), MEAN-RS (162 vs. 148), MIN-RS (65 vs. 64) and total wpm (2023 vs. 1721, p = 0.003) were lower in PD participants. Higher CPS values and lower logMAR/logRAD (99.73% vs. 95%, p = 0.002) in PD participants indicated poorer reading performance (0.17 vs. 0.27, p < 0.001). No significant differences were found between PD participants at different Hoehn and Yahr stages, but a trend towards worsening was observed.
conclusionsParticipants with PD experience significant reading problems compared with CG, underscoring the necessity for targeted interventions. These findings highlight the importance of assessing reading skills to understand the limitations that people with PD face daily. Future research should focus on identifying specific treatment strategies and exploring additional factors that may improve reading performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.